A revolution is coming, and it will likely reshape the pharmaceutical landscape and significantly impact its many participants: including patients, both large and small drug companies, generic drug manufacturers, regulators, health insurers, venture capitalists, and federal and state governments. The revolution is a cures revolution — ushered in by therapeutics that have the ability to cure diseases rather than merely
treat their symptoms.

Click here to read the full article.